Feed aggregator

Prime Medicine Gets FDA Okay for First Trial of Gene Editing Technique

Biospace news - Tue, 04/30/2024 - 02:00
Prime Medicine Gets FDA Okay for First Trial of Gene Editing Technique 4/30/2024

A Takeda Oncology Leader’s Passion Fuels A Patient-First Approach

Biospace news - Tue, 04/30/2024 - 02:00
A Takeda Oncology Leader’s Passion Fuels A Patient-First Approach 4/30/2024

Healthy lifestyle may offset effects of life-shortening genes by 60%+

World Pharma News - Mon, 04/29/2024 - 10:00
A healthy lifestyle may offset the effects of life-shortening genes by more than 60%, suggests an analysis of the findings from several large long term studies, published online in the journal BMJ Evidence Based Medicine.

While genes and lifestyle seem to have an additive effect on a person's lifespan, an unhealthy lifestyle is independently linked to a 78% heightened risk of dying before one’s time, regardless of genetic predisposition, the research indicates.

Ono to Buy Deciphera for $2.4B, Looks to Expand Cancer Pipeline and US Footprint

Biospace news - Mon, 04/29/2024 - 02:00
Ono to Buy Deciphera for $2.4B, Looks to Expand Cancer Pipeline and US Footprint 4/29/2024

BMS, Repertoire Ink Potential $1.8B Deal to Find Vaccines for Autoimmune Diseases

Biospace news - Mon, 04/29/2024 - 02:00
BMS, Repertoire Ink Potential $1.8B Deal to Find Vaccines for Autoimmune Diseases 4/29/2024

FDA Approves First Targeted Treatment for WHIM Syndrome

Biospace news - Mon, 04/29/2024 - 02:00
FDA Approves First Targeted Treatment for WHIM Syndrome 4/29/2024

J&J-Partnered Addex Fails Phase II Epilepsy Study, Mulls Future of Candidate

Biospace news - Mon, 04/29/2024 - 02:00
J&J-Partnered Addex Fails Phase II Epilepsy Study, Mulls Future of Candidate 4/29/2024

Bavarian Nordic’s Mpox Vaccine Safe, Effective at Lower Doses: Study

Biospace news - Mon, 04/29/2024 - 02:00
Bavarian Nordic’s Mpox Vaccine Safe, Effective at Lower Doses: Study 4/29/2024

Safety Concerns with MorphoSys’ Blood Cancer Drug Could Mar $2.9B Novartis Buy: STAT

Biospace news - Mon, 04/29/2024 - 02:00
Safety Concerns with MorphoSys’ Blood Cancer Drug Could Mar $2.9B Novartis Buy: STAT 4/29/2024

Pharma R&D ROI Spikes in 2023 as ‘Breakthroughs’ Re-Energize Industry: Report

Biospace news - Mon, 04/29/2024 - 02:00
Pharma R&D ROI Spikes in 2023 as ‘Breakthroughs’ Re-Energize Industry: Report 4/29/2024

What’s Next for Obesity Therapeutics? Higher Quality Weight Loss

Biospace news - Mon, 04/29/2024 - 02:00
What’s Next for Obesity Therapeutics? Higher Quality Weight Loss 4/29/2024

As Autism Cases Rise, Biopharma Springs Into Action

Biospace news - Mon, 04/29/2024 - 02:00
As Autism Cases Rise, Biopharma Springs Into Action 4/29/2024

5 Mid-Stage ALS Drugs to Watch

Biospace news - Mon, 04/29/2024 - 02:00
5 Mid-Stage ALS Drugs to Watch 4/29/2024

Opinion: Larimar Could Compete with Biogen in Friedreich’s Ataxia

Biospace news - Mon, 04/29/2024 - 02:00
Opinion: Larimar Could Compete with Biogen in Friedreich’s Ataxia 4/29/2024

U.S. FDA approves Pfizer's BEQVEZ™ (fidanacogene elaparvovec-dzkt), a one-time gene therapy for adults with Hemophilia B

World Pharma News - Fri, 04/26/2024 - 10:00
Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved BEQVEZ™ (fidanacogene elaparvovec-dzkt) for the treatment of adults with moderate to severe hemophilia B who currently use factor IX (FIX) prophylaxis therapy, or have current or historical life-threatening hemorrhage, or have repeated, serious spontaneous bleeding episodes, and do not have neutralizing antibodies to adeno-associated virus serotype Rh74var (AAVRh74var) capsid as detected by an FDA-approved test.

AbbVie Raises 2024 Profit Outlook, Reports Strong Q1 Sales for Skyrizi and Rinvoq

Biospace news - Fri, 04/26/2024 - 02:00
AbbVie Raises 2024 Profit Outlook, Reports Strong Q1 Sales for Skyrizi and Rinvoq 4/26/2024

Pfizer Secures FDA Approval for Hemophilia B Gene Therapy, Launches Warranty

Biospace news - Fri, 04/26/2024 - 02:00
Pfizer Secures FDA Approval for Hemophilia B Gene Therapy, Launches Warranty 4/26/2024

Gilead Touts 5% Revenue Jump, Positions for 2024 Growth and Culls Pipeline

Biospace news - Fri, 04/26/2024 - 02:00
Gilead Touts 5% Revenue Jump, Positions for 2024 Growth and Culls Pipeline 4/26/2024

GSK Sues Pfizer and BioNTech Over Alleged COVID-19 Patent Infringement

Biospace news - Fri, 04/26/2024 - 02:00
GSK Sues Pfizer and BioNTech Over Alleged COVID-19 Patent Infringement 4/26/2024

Cigna’s Evernorth to Offer Humira Biosimilar with No Out-of-Pocket Cost

Biospace news - Fri, 04/26/2024 - 02:00
Cigna’s Evernorth to Offer Humira Biosimilar with No Out-of-Pocket Cost 4/26/2024